New insights into copper monooxygenases and peptide amidation: Structure, mechanism and function

Cellular and Molecular Life Sciences

Volumn 57, Issue 8-9, 2000, Pages 1236-1259

  Prigge, S T ^a   Mains, R E ^a   Eipper, B A ^a   Amzel, L M ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Amidation; Ascorbate; Copper; Dopamine monooxygenase; Electron transfer; Oxygen chemistry; Peptide hormones; Peptidylglycine amidating monooxygenase; Structure

Indexed keywords

AMIDASE; UNSPECIFIC MONOOXYGENASE;

ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME MECHANISM; ENZYME STRUCTURE; ENZYME SUBSTRATE; HUMAN; HYDROXYLATION; NONHUMAN; REVIEW;

EID: 0000821179     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00000763     Document Type: Review

References (169)

1. 1 Bradbury A. F. and Smyth D. G. (1991) Peptide amidation. Trends Biochem. Sci. 16: 112-115
2. 2 Patel Y. C. and Galanopoulou A. (1995) Processing and intracellular targeting of prosomatostatin-derived peptides: the role of mammalian endoproteases. Ciba. Found. Symp. 190: 26-50
3. 3 Lindberg I. and Zhou Y. (1995) Overexpression of neuropeptide precursors and processing enzymes. Methods Neurosci. 23: 94-108
4. 4 Rouille Y., Duguay S. J., Lund K., Furuta M., Gong Q., Lipkind G. et al. (1995) Proteolytic processing mechanisms in the biosynthesis of neuroendocrine peptides. Front. Neuroendocrinol. 16: 322-361
5. 5 Yoon J. and Beinfeld M. C. (1997) Prohormone convertase 1 is necessary for the formation of cholecystokinin 8 in Rin5F and STC-1 cells. J. Biol. Chem. 272: 9450-9456
6. 6 Day R., Lazure C., Basak A., Boudreault A., Limperis P., Dong W. et al. (1998) Prodynorphin processing by pro-protein convertase 2. Cleavage at single basic residues and enhanced processing in the presence of carboxypeptidase activity. J. Biol. Chem. 273: 829-836
7. 7 Seidah N. G., Day R., Marcinkiewicz M. and Chretien M. (1998) Precursor convertases: an evolutionary ancient, cell-specific, combinatorial mechanism yielding diverse bioactive peptides and proteins. Ann. N. Y. Acad. Sci. 839: 9-24
8. 8 Zhou A., Webb G., Zhu X. and Steiner D. F. (1999) Proteolytic processing in the secretory pathway. J. Biol. Chem. 274: 20745-20748
9. 9 Cuttitta F. (1993) Peptide amidation: signature of bioactivity. Anat. Rec. 236: 87-93, 172-173; discussion 193-175
10. 10 Merkler D. J. (1994) C-terminal amidated peptides: production by the in vitro enzymatic amidation of glycine-extended peptides and the importance of the amide to bioactivity. Enzyme Microb. Technol. 16: 450-456
11. 11 Kolhekar A. S., Roberts M. S., Jiang N., Johnson R. C., Mains R. E., Eipper B. A. et al. (1997) Neuropeptide amidation in Drosophila: separate genes encode the two enzymes catalyzing amidation. J. Neurosci. 17: 1363-1376
12. 12 Eipper B. A., Milgram S. L., Husten E. J., Yun H. Y. and Mains R. E. (1993) Peptidylglycine alpha-amidating monooxygenase: a multifunctional protein with catalytic, processing, and routing domains. Protein Sci. 2: 489-497
13. 13 Eipper B. A., Quon A. S., Mains R. E., Boswell J. S. and Blackburn N. J. (1995) The catalytic core of peptidylglycine alpha-hydroxylating monooxygenase: investigation by site-directed mutagenesis, Cu X-ray absorption spectroscopy, and electron paramagnetic resonance. Biochemistry 34: 2857-2865
14. 14 Kulathila R., Merkler K. A. and Merkler D. J. (1999) Enzymatic formation of C-terminal amides. Nat. Prod. Rep. 16: 145-154
15. 15 Freeman J. C., Villafranca J. J. and Merkler D. J. (1993) Redox cycling of enzyme-bound copper during peptide amidation. J. Am. Chem. Soc. 115: 4923-4924
16. 16 May V., Mains R. E. and Eipper B. A. (1989) Ability of cofactors to support peptide amidation is cell-type specific. Horm. Res. 32: 18-21
17. 17 Murthy A. S., Keutmann H. T. and Eipper B. A. (1987) Further characterization of peptidylglycine alpha-amidating monooxygenase from bovine neurointermediate pituitary. Mol. Endocrinol. 1: 290-299
18. 18 Kolhekar A. S., Mains R. E. and Eipper B. A. (1997) Peptidylglycine alpha-amidating monooxygenase: an ascorbate-requiring enzyme. Methods Enzymol. 279: 35-43
19. 19 May V. and Eipper B. A. (1985) Regulation of peptide amidation in cultured pituitary cells. J. Biol. Chem. 260: 16224-16231
20. 20 Mains R. E., Myers A. C. and Eipper B. A. (1985) Hormonal, drug and dietary factors affecting peptidyl glycine alpha-amidating monooxygenase activity in various tissues of the adult male rat. Endocrinology 116: 2505-2515
21. 21 Li C., Oldham C. D. and May S. W. (1994) NN-dimethyl-1,4-phenylenediamine as an alternative reductant for peptidylglycine alpha-amidating mono-oxygenase catalysis. Biochem J. 300: 31-36
22. 22 Bell J., Ash D. E., Snyder L. M., Kulathila R., Blackburn N. J. and Merkler D. J. (1997) Structural and functional investigations on the role of zinc in bifunctional rat peptidylglycine alpha-amidating enzyme. Biochemistry 36: 16239-16246
23. 23 Eipper B. A., Stoffers D. A. and Mains R. E. (1992) The biosynthesis of neuropeptides: peptide alpha-amidation. Annu. Rev. Neurosci. 15: 57-85
24. 24 Leviev I., Williamson M. and Grimmelikhuijzen C. J. (1997) Molecular cloning of a preprohormone from Hydra magnipapillata containing multiple copies of Hydra-L Wamide (Leu-Trp-NH2) neuropeptides: evidence for processing at Ser and Asn residues. J. Neurochem. 68: 1319-1325
25. 25 Maule A. G., Bowman J. W., Thompson D. P., Marks N. J., Friedman A. R. and Geary T. G. (1996) FMRFamide-related peptides (FaRPs) in nematodes: occurrence and neuromuscular physiology. Parasitology 113: S119-135
26. 26 Takahashi T., Muneoka Y., Lohmann J., Lopez de Haro M. S., Solleder G., Bosch T. C. et al. (1997) Systematic isolation of peptide signal molecules regulating development in Hydra: L Wamide and PW families. Proc. Natl. Acad. Sci. USA 94: 1241-1246
27. 27 Destoumieux D., Bulet P., Loew D., Van Dorsselaer A., Rodriguez J. and Bachere E. (1997) Penaeidins, a new family of antimicrobial peptides isolated from the shrimp Penaeus rannamei (Decapoda). J. Biol. Chem. 272: 28398-28406
28. 28 Lackey D. B. (1992) Isolation and structural determination of a novel TRH-like tripeptide, pyroGlu-Tyr-Pro amide, from alfalfa. J. Biol. Chem. 267: 17508-17511
29. 29 Gigoux V., Escrieut C., Fehrentz J. A., Poirot S., Maigret B., Moroder L. et al. (1999) Arginine 336 and asparagine 333 of the human cholecystokinin-A receptor binding site interact with the penultimate aspartic acid and the C-terminal amide of cholecystokinin. J. Biol. Chem. 274: 20457-20464
30. 30 Edison A. S., Espinoza E. and Zachariah C. (1999) Conformational ensembles: the role of neuropeptide structures in receptor binding. J. Neurosci. 19: 6318-6326
31. 31 Bignon E., Alonso R., Arnone M., Boigegrain R., Brodin R., Gueudet C. et al. (1999) SR 146131: a new potent, orally active and selective nonpeptide cholecystokinin subtype 1 receptor agonist. II. In vivo pharmacological characterization. J. Pharmacol. Exp. Ther. 289: 752-761
32. 32 Lingueglia E., Champigny G., Lazdunski M. and Barbry P. (1995) Cloning of the amiloride-sensitive FMRFamide peptide-gated sodium channel. Nature 378: 730-733
33. 33 Kumar A. M., Agarwal R. K., Thompson M. L., Marchand J. E., Kream R. M. and Engelking L. R. (1994) Effect of chronic DDC treatment on LHRH and substance P amidation processes in the rat. Brain Res. Bull. 33: 337-344
34. 34 Kaise M., Muraoka A., Seva C, Takeda H., Dickinson C. J. and Yamada T. (1995) Glycine-extended progastrin processing intermediates induce H + , K(+)-ATPase alpha-subunit gene expression through a novel receptor. J. Biol. Chem. 270: 11155-11160
35. 35 Dockray G. J., Varro A. and Dimaline R. (1996) Gastric endocrine cells: gene expression, processing, and targeting of active products. Physiol. Rev. 76: 767-798
36. 36 Kapuscinski M., Green M., Sinha S. N., Shepherd J. J. and Shulkes A. (1993) Peptide alpha-amidation activity in human plasma: relationship to gastrin processing. Clin. Endocrinol. 39: 51-58
37. 37 Kitamura K., Kato J., Kawamoto M., Tanaka M., Chino N., Kangawa K. et al. (1998) The intermediate form of glycine-extended adrenomedullin is the major circulating molecular form in human plasma. Biochem. Biophys. Res. Commun. 244: 551-555
38. 38 Amico J. A. and Hempel J. (1990) An oxytocin precursor intermediate circulates in the plasma of humans and rhesus monkeys administered estrogen. Neuroendocrinology 51: 437-443
39. 39 Seva C., Dickinson C. J. and Yamada T. (1994) Growth-promoting effects of glycine-extended progastrin. Science 265: 410-412
40. 40 Todísco A., Takeuchi Y., Seva C., Dickinson C. J. and Yamada T. (1995) Gastrin and glycine-extended progastrin processing intermediates induce different programs of early gene activation. J. Biol. Chem. 270: 28337-28341
41. 41 Grimmelikhuijzen C. J. P., Darmer D., Schmutzler C., Reinscheid R. K. and Carstensen K. (1994) Biosynthesis of neuropeptides in the Cnidaria: new discoveries of old principles. Perspectives Comp. Endocrinol. 97-108
42. 42 Mitgutsch C., Hauser F. and Grimmelikhuijzen C. J. P. (1999) Expression and developmental regulation of the hydra-RFamide and hydra-L Wamide preprohormone genes in Hydra: evidence for transient phases of head formation. Dev. Biol. 207: 189-203
43. 43 Schmich J., Trepel S. and Leitz T. (1998) The role of GL Wamides in metamorphosis of Hydractinia echinata. Dev. Genes Evol. 208: 267-273
44. 44 Xin Y., Hurwitz I., Perrins R., Evans C. G., Alexeeva V., Weiss K. R. and Kupfermann I. (1999) Actions of a pair of identified cerebral-buccal interneurons (CBI-8,9) in Aplysia that contain the peptide myomodulin. J. Neurophysiol. 81: 507-520
45. 45 Wang Y., Strong J. A. and Sahley C. L. (1999) Modulatory effects of myomodulin on the excitability and membrane currents in Retzius cells of the leech. J. Neurophysiol. 82: 216-225
46. 46 Nelson L. S., Rosoff M. L. and Li C. (1998) Disruption of a neuropeptide gene, flp-1, causes multiple behavioral defects in Caenorhabditis elegens. Science 281: 1686-1690
47. 47 Martinez A., Miller M. J., Unsworth E. J., Siegfried J. M. and Cuttitta F. (1995) Expression of adrenomedullin in normal human lung and in pulmonary tumors. Endocrinology 136: 4099-4105
48. 48 Eguchi S., Hirata Y., Iwasaki H., Sato K., Watanabe T. X., Inui T. et al. (1994) Structure-activity relationship of adrenomedullin, a novel vasodilatory peptide, in cultured rat vascular smooth muscle cells. Endocrinology 135: 2454-2458
49. 49 Arimura A., Somogyvari-Vigh A., Weill C., Fiore R. C., Tatsuno I., Bay V. et al. (1994) PACAP functions as a neurotrophic factor. Ann. N.Y. Acad. Sci. 739: 228-243
50. 50 De Felipe C., Pinnock R. D. and Hunt S. P. (1995) Modulation of chemotropism in the developing spinal cord by substance P. Science 267: 899-902
51. 51 Dickinson C. J., Daugherty D., Guo Y. J., Stadler B., Finniss S. and Yamada T. (1993) Substrate specificity of the gastrin-amidating enzyme. J. Biol. Chem. 268: 15929-15934
52. 52 Landymore-Lim A. E., Bradbury A. F. and Smyth D. G. (1983) The amidating enzyme in pituitary will accept a peptide with C-terminal D-alanine as substrate. Biochem. Biophys. Res. Commun. 117: 289-293
53. 53 Katopodis A. G. and May S. W. (1990) Novel substrates and inhibitors of peptidylglycine alpha-amidating monooxygenase. Biochemistry 29: 4541-4548
54. 54 Merkler D. J., Merkler K. A., Stern W. and Fleming F. F. (1996) Fatty acid amide biosynthesis: a possible new role for peptidylglycine alpha-amidating enzyme and acyl-coenzyme A: glycine N-acyltransferase. Arch. Biochem. Biophys. 330: 430-434
55. 55 Wilcox B. J., Ritenour-Rodgers K. J., Asser A. S., Baumgart L. E., Baumgart M. A., Boger D. E. et al. (1999) N-acylglycine amidation: implications for the biosynthesis of fatty acid primary amides. Biochemistry 38: 3235-3245
56. 56 Merkler D. J., Glufke U., Ritenour-Rodgers K. J., Baumgart L. E., DeBlassio J. L., Merkler K. A. et al. (1999) Formation of nicotinamide from nicotinuric acid by peptidylglycine alpha-amidating monooxygenase (PAM): a possible alternative route from nicotinic acid (niacin) to NADP in mammals. J. Am. Chem. Soc. 121: 4904-4905
57. 57 Cravatt B. F., Prospero-Garcia O., Siuzdak G., Gilula N. B., Henriksen S. J., Boger D. L. et al. (1995) Chemical characterization of a family of brain lipids that induce sleep. Science 268: 1506-1509
58. 58 Boger D. L., Patterson J. E., Guan X., Cravatt B. F., Lerner R. A. and Gilula N. B. (1998) Chemical requirements for inhibition of gap junction communication by the biologically active lipid oleamide. Proc. Natl. Acad. Sci. USA 95: 4810-4815
59. 59 Oldham C. D., Li C., Girard P. R., Nerem R. M. and May S. W. (1992) Peptide amidating enzymes are present in cultured endothelial cells. Biochem. Biophys. Res. Commun. 184: 323-329
60. 60 Saldise L., Martinez A., Montuenga L. M., Treston A., Springall D. R., Polak J. M. et al. (1996) Distribution of peptidyl-glycine alpha-amidating mono-oxygenase (PAM) enzymes in normal human lung and in lung epithelial tumors. J. Histochem. Cytochem. 44: 3-12
61. 61 Ogonowski A. A., May S. W., Moore A. B., Barrett L. T., O'Bryant C. L. and Pollock S. H. (1997) Antiinflammatory and analgesic activity of an inhibitor of neuropeptide amidation. J. Pharmacol. Exp. Ther. 280: 846-853
62. 62 Klein R S. and Fricker L. D. (1992) Heterogeneous expression of carboxypeptidase E and proenkephalin mRNAs by cultured astrocytes. Brain Res. 569: 300-310
63. th Ann. Mtg. Abst. 428.10
64. 64 Zhang J., Zheng M., Eipper B. A. and Pintar J. E. (1997) Embryonic and uterine expression patterns of peptidylglycine alpha-amidating monooxygenase transcripts suggest a widespread role for amidated peptides in development. Dev. Biol. 192: 375-391
65. 65 Martinez A. and Treston A. M. (1996) Where does amidation take place? Mol. Cell. Endocrinol. 123: 113-117
66. 66 Scopsi L., Lee R., Gullo M., Collini P., Husten E. J. and Eipper B. A. (1998) Peptidylglycine alpha-amidating monooxygenase in neuroendocrine tumors. Appl. Immunohistochem. 6: 120-132
67. 67 Siegfried J. M., Han Y.-H., DcMichcle M. A., Hunt J. D., Gaither A. L. and Cuttitta F. (1994) Production of gastrin-releasing peptide by a non-small cell lung carcinoma cell line adapted to serum-free and growth factor-free conditions. J. Biol. Chem. 269: 8596-8603
68. 68 Iwai N., Martinez A., Miller M. J., Vos M., Mulshine J. L. and Treston A. M. (1999) Autocrine growth loops dependent on peptidyl alpha-amidating enzyme as targets for novel tumor cell growth inhibitors. Lung Cancer 23: 209-222
69. 69 Oyarce A. M., Hand T. A., Mains R. E. and Eipper B. A. (1996) Dopaminergic regulation of secretory granule-associated proteins in rat intermediate pituitary. J. Neurochem. 67: 229-241
70. 70 Grino M., Guillaume V., Boudouresque E., Conte-Devolx B., Maltese J. Y. and Oliver C. (1990) Glucocorticoids regulate peptidyl-glycine alpha-amidating monooxygenase gene expression in the rat hypothalamic paraventricular nucleus. Mol. Endocrinol. 4: 1613-1619
71. 71 El Meskini R., Delfino C., Boudouresque E., Hery M., Oliver C. and Ouafik L. (1997) Estrogen regulation of peptidylglycine alpha-amidating monooxygenase expression in anterior pituitary gland. Endocrinology 138: 379-388
72. 72 El Meskini R., Delfino C., Boudouresque F., Oliver C, Martin P. M. and Ouafik L. H. (1998) Evidence of high expression of peptidylglycine alpha-amidating monooxygenase in the rat uterus: estrogen regulation. Proc. Natl. Acad. Sci. USA 95: 7191-7196
73. 73 Mueller G. P., Husten E. J., Mains R. E. and Eipper B. A. (1993) Peptide alpha-amidation and peptidylglycine alpha-hydroxylating monooxygenase: control by disulfiram. Mol. Pharmacol. 44: 972-980
74. 74 Driscoll W. J., Mueller S. A., Eipper B. A. and Mueller G. P. (1999) Differential regulation of peptide alpha-amidation by dexamethasone and disulfiram. Mol. Pharmacol. 55: 1067-1076
75. 75 Zabriskie T. M., Cheng H. and Vederas J. C. (1992) Mechanism-based inactivation of peptidylglycine alpha-hydroxylating monooxygenase (PHM) by a substrate analogue, D-phenylalanyl-L-phenylalanyl-D-vinylglyeine: inhibition of formation of peptide C-terminal amides. J. Am. Chem. Soc. 114: 2270-2272
76. 76 Mueller G. P., Driscoll W. J. and Eipper B. A. (1999) In vivo inhibition of peptidylglycine-alpha-hydroxylating monooxygenase by 4-phenyl-3-butenoic acid. J. Pharmacol. Exp. Ther. 290: 1331-1336
77. 77 Bolkenius F. N., Ganzhorn A. J., Chanal M. C. and Danzin C. (1997) Selective mechanism-based inactivation of peptidylglycine alpha-hydroxylating monooxygenase in serum and heart atrium vs. brain. Biochem. Pharmacol. 53: 1695-1702
78. 78 Merkler D. J., Kulathila R. and Ash D. E. (1995) The inactivation of bifunctional peptidylglycine alpha-amidating enzyme by benzylhydrazine: evidence that the two enzyme-bound copper atoms are nonequivalent. Arch. Biochem. Biophys. 317: 93-102
79. 79 Moore A. B. and May S. W. (1999) Kinetic and inhibition studies on substrate channeling in the bifunctional enzyme catalyzing C-terminal amidation. Biochem. J. 341: 33-40
80. 80 Jeng A. Y., Fujimoto R. A., Chou M., Tan J. and Erion M. D. (1997) Suppression of substance P biosynthesis in sensory neurons of dorsal root ganglion by prodrug esters of potent peptidylglycine alpha-amidating monooxygenase inhibitors. J. Biol. Chem. 272: 14666-14671
81. 81 Erion M. D., Tan J., Wong M. and Jeng A. Y. (1994) Inhibition of peptidylglycine alpha-amidating monooxygenase by N-substituted homocystcine analogs. J. Med. Chem. 37: 4430-4437
82. 82 Mounier C. E., Shi J., Sirimanne S. R., Chen B. H., Moore A. B., Gill-Woznichak M. M. et al. (1997) Pyruvate-extended amino acid derivatives as highly potent inhibitors of carboxyl-terminal peptide amidation. J. Biol. Chem. 272: 5016-5023
83. 83 Guembe L., Villaro A. C. and Treston A. M. (1999) Immunocytochemical mapping of the amidating enzyme PAM in the developing and adult mouse lung. J. Histochem. Cytochem. 47: 623-636
84. 84 Fenger M. and Hilsted L. (1988) Influence of ascorbic acid on in vivo amidation of alpha-melanocyte stimulating hormone in guinea pig pituitary. Acta. Endocrinol. 118: 119-124
85. 85 Marchand J. E., Shimonaka H. and Kream R. M. (1991) Biochemical characterization and anatomical distribution of a major form of unamidated precursor of substance P in rat brain. Brain Res. 567: 290-305
86. 86 Tsukaguchi H., Tokui T., Mackenzie B., Berger U. V., Chen X. Z., Wang Y. et al. (1999) A family of mammalian Na + -dependent L-ascorbic acid transporters. Nature 399: 70-75
87. 87 Hamman B. D., Hendershot L. M. and Johnson A. E. (1998) BiP maintains the permeability barrier of the ER membrane by scaling the lumenal end of the translocon pore before and early in translocation. Cell 92: 747-758
88. 88 Matlack K. E., Misselwitz B., Plath K. and Rapoport T. A. (1999) BiP acts as a molecular ratchet during posttranslational transport of prepro-alpha factor across the ER membrane. Cell 97: 553-564
89. 89 Fleming P. J. and Kent U. M. (1991) Cytochrome b561. ascorbic acid, and transmembrane electron transfer. Am. J. Clin. Nutr. 54: 1173S-1178S
90. 90 Njus D. and Kelley P. M. (1993) The secretory-vesicle ascorbate-regenerating system: a chain of concerted H + e(-)-transfer reactions. Biochim. Biophys. Acta. 1144: 235-248
91. 91 Ingebretsen O. C., Terland O. and Flatmark T. (1980) Subcellular distribution of ascorbate in bovine adrenal medulla. Evidence for accumulation in chromaffin granules against a concentration gradient. Biochim. Biophys. Acta 628: 182-189
92. 92 Srivastava M. (1995) Genomic structure and expression of the human gene encoding cytochrome b561, an integral protein of the chromaffin granule membrane. J. Biol. Chem. 270: 22714-22720
93. 93 Prigge S. T., Kolhekar A. S., Eipper B. A., Mains R. E. and Amzel L. M. (1999) Substrate-mediated electron transfer in peptidylglycine alpha-hydroxylating monooxygenase. Nat. Struct. Biol. 6: 976-983
94. 94 Harris Z. L. and Gitlin J. D. (1996) Genetic and molecular basis for copper toxicity. Am. J. Clin. Nutr. 63: 836S-841S
95. 95 Mercer J. F. (1998) Menkes syndrome and animal models. Am. J. Clin. Nutr. 67: 1022S-1028S
96. 96 Petris M. J., Mercer J. F., Culvenor J. G., Lockhart P., Gleeson P. A. and Camakaris J. (1996) Ligand-regulated transport of the Menkes copper P-type ATPase efflux pump from the Golgi apparatus to the plasma membrane: a novel mechanism of regulated trafficking. EMBO J. 15: 6084-6095
97. 97 Turner Z. and Horn N. (1997) Menkes disease: recent advances and new aspects. J. Med. Genet. 34: 265-274
98. 98 Yamaguchi Y., Heiny M. E., Suzuki M. and Gitlin J. D. (1996) Biochemical characterization and intracellular localization of the Menkes disease protein. Proc. Natl. Acad. Sci. USA 93: 14030-14035
99. 99 Prohaska J. R., Tamura T., Percy A. K. and Turnlund J. R. (1997) In vitro copper stimulation of plasma peptidylglycine alpha-amidating monooxygenase in Menkes disease variant with occipital horns. Pediatr. Res. 42: 862-865
100. 100 Pufahl R. A., Singer C. P., Peariso K. L., Lin S.-J., Schmidt P. J., Fahrni C. J. et al. (1997) Metal ion chaperone function of the soluble Cu(I) receptor Atxl. Science 278: 853-856
101. 101 Koch K. A., Pena M. M. and Thiele D. J. (1997) Copper-binding motifs in catalysis, transport, detoxification and signaling. Chem. Biol. 4: 549-560
102. 102 Culotta V. C., Klomp L. W., Strain J., Casareno R. L., Krems B. and Gitlin J. D. (1997) The copper chaperone for Superoxide dismutase. J. Biol. Chem. 272: 23469-23472
103. 103 Larin D., Mekios C., Das K., Ross B., Yang A. S. and Gilliam T. C. (1999) Characterization of the interaction between the Wilson and Menkes disease proteins and the cytoplasmic copper chaperone, HAH1p. J. Biol. Chem. 274: 28497-28504
104. 104 Yun H. Y. and Eipper B. A. (1995) Addition of an endoplasmic reticulum retention/retrieval signal does not block maturation of enzymatically active peptidylglycine alpha-amidating monooxygenase. J. Biol. Chem. 270: 15412-15416
105. 105 Arvan P. and Castle D. (1998) Sorting and storage during secretory granule biogenesis: looking backward and looking forward. Biochem J. 332: 593-610
106. 106 Urbe S., Tooze S. A. and Barr F. A. (1997) Formation of secretory vesicles in the biosynthetic pathway. Biochim. Biophys. Acta 1358: 6-22
107. 107 Bauerfeind R., Galli T. and DC Camilli P. (1996) Molecular mechanisms in synaptic vesicle recycling. J. Neurocytol. 25: 701-715
108. 108 Dannies P. S. (1999) Protein hormone storage in secretory granules: mechanisms for concentration and sorting. Endocr. Rev. 20: 3-21
109. 109 Thiele C., Gerdes H. H. and Huttner W.B. (1997) Protein secretion: puzzling receptors. Curr. Biol. 7: R496-R500
110. 110 Milgram S. L., Eipper B. A. and Mains R. E. (1994) Differential trafficking of soluble and integral membrane secretory granule-associated proteins. J. Cell Biol. 124: 33-41
111. 111 Milgram S. L., Kho S. T., Martin G. V., Mains R. E. and Eipper B. A. (1997) Localization of integral membrane peptidylglycine alpha-amidating monooxygenase in neuroendocrine cells. J. Cell Sci. 110: 695-706
112. 112 Alam M. R., Johnson R. C., Darlington D. N., Hand T. A., Mains R. E. and Eipper B. A. (1997) Kalirin, a cytosolic protein with spectrin-like and GDP/GTP exchange factor-like domains that interacts with peptidylglycine alpha-amidating monooxygenase, an integral membrane peptide-processing enzyme. J. Biol. Chem. 272: 12667-12675
113. 113 Wulff B. S., Catipovic B., Okamoto H., Gether U., Schwartz T. W. and Johansen T. E. (1993) Efficient amidation of C-peptide deleted NPY precursors by non-endocrine cells is affected by the presence of Lys-Arg at the C-terminus. Mol. Cell. Endocrinol. 91: 135-141
114. 114 Takahashi K. I., Liu Y. C., Hayashi N., Goto F., Kato M., Kawashima H. et al. (1997) Production of bioactive salmon calcitonin from the nonendocrine cell lines COS-7 and CHO. Peptides 18: 439-444
115. 115 McKee C., Gibson A., Dalrymple M., Emslie L., Garner I. and Cottingham I. (1998) Production of biologically active salmon calcitonin in the milk of transgenic rabbits. Nat. Biotechnol. 16: 647-651
116. 116 Eipper B. A., Green C. B., Campbell T. A., Stoffers D. A., Keutmann H. T., Mains R. E. et al. (1992) Alternative splicing and endoproteolytic processing generate tissue-specific forms of pituitary peptidylglycine alpha-amidating monooxygenase (PAM). J. Biol. Chem. 267: 4008-4015
117. 117 Staffers D. A., Ouafik L. and Eipper B. A. (1991) Characterization of novel mRNAs encoding enzymes involved in peptide alpha-amidation. J. Biol. Chem. 266: 1701-1707
118. 118 Ouafik L. H., Stoffers D. A., Campbell T. A., Johnson R. C., Bloomquist B. T., Mains R. E. et al. (1992) The multi-functional peptidylglycine alpha-amidating monooxygenase gene: exon/intron organization of catalytic, processing and routing domains. Mol. Endocrinol. 6: 1571-1584
119. 119 Glauder J., Ragg H., Rauch J. and Engels J. W. (1990) Human peptidylglycine alpha-amidating monooxygenase: cDNA, cloning and functional expression of a truncated form in COS cells. Biochem. Biophys. Res. Commun. 169: 551-558
120. 120 Vos M. D., Jones J. E. and Treston A. M. (1995) Human peptidylglycine alpha-amidating monooxygenase transcripts derived by alternative mRNA splicing of an unreported exon. Gene 163: 307-311
121. 121 Husten E. J., Tausk F. A., Keutmann H. T. and Eipper B. A. (1993) Use of endoproteases to identify catalytic domains, linker regions, and functional interactions in soluble peptidylglycine alpha-amidating monooxygenase. J. Biol. Chem. 268: 9709-9717
122. 122 Husten E. J. and Eipper B. A. (1991) The membrane-bound bifunctional peptidylglycine alpha-amidating monooxygenase protein. Exploration of its domain structure through limited proteolysis. J. Biol. Chem. 266: 17004-17010
123. 123 Kolhekar A. S., Keutmann H. T., Mains R. E., Quon A. S. W. and Eipper B. A. (1997) Peptidylglycine alpha-hydroxylating monooxygenase: active site residues, disulfide linkages, and a two-domain model of the catalytic core. Biochemistry 36: 10901-10909
124. 124 Kolhekar A. S., Quon A. S., Berard C. A., Mains R. E. and Eipper B. A. (1998) Post-translational N-glycosylation of a truncated form of a peptide processing enzyme. J. Biol. Chem. 273: 23012-23018
125. 125 Iwasaki Y., Shimoi H., Saiki H. and Nishikawa Y. (1993) Tissue-specific molecular diversity of amidating enzymes (peptidylglycine alpha-hydroxylating monooxygenase and peptidylhydroxyglycine N-C lyase) in Xenopux laevis. Eur. J. Biochem. 214: 811-818
126. 126 Spijker S., Smit A. B., Eipper B. A., Malik A., Mains R. E. and Geraerts W. P. (1999) A molluscan peptide alpha-amidating enzyme precursor that generates five distinct enzymes. FASEB J. 13: 735-748
127. 127 Hauser F., Williamson M. and Grimmelikhuijzen C. J. (1997) Molecular cloning of a peptidylglycine alpha-hydroxylating monooxygenase from sea anemones. Biochem. Biophys. Res. Commun. 241: 509-512
128. 128 Kim H., Kelly R. E. and Evans D. R. (1992) The structural organization of the hamster multifunctional protein CAD. Controlled proteolysis, domains and linkers. J. Biol. Chem. 267: 7177-7184
129. 129 Guy H. I. and Evans D. R. (1994) Cloning and expression of the mammalian multifunctional protein CAD in Escherichia coli. Characterization of the recombinant protein and a deletion mutant lacking the major interdomain linker. J. Biol. Chem. 269: 23808-23816
130. 130 Green J. D., Perham R. N., Ullrich S. J. and Appella E. (1992) Conformational studies of the interdomain linker peptides in the dihydrolipoyl acetyltransferase component of the pyruvate drhydrogenase multienzyme complex of Escherichia coli. J. Biol. Chem. 267: 23484-23488
131. 131 Southan C. and Kruse L. I. (1989) Sequence similarity between dopamine beta-hydroxylase and peptide alpha-amidating enzyme: evidence for a conserved catalytic domain. FEBS Lett. 255: 116-120
132. 132 Robertson J. G., Adams G. W., Medzihradszky K. F., Burlingame A. L. and Villafranca J. J. (1994) Complete assignment of disulfide bonds in bovine dopamine beta-hydroxylase. Biochemistry 33: 11563-11575
133. 133 Kobayashi K., Kurosawa Y., Fujita K. and Nagatsu T. (1989) Human dopamine beta-hydroxylase gene: two mRNA types having different 3′-terminal regions are produced through alternative polyadenylation. Nucleic Acids Res. 17: 1089-1102
134. 134 Chambers K. J., Tonkin L. A., Chang E., Shelton D. N., Linskens M. H. and Funk W. D. (1998) Identification and cloning of a sequence homologue of dopamine beta-hydroxylase. Gene 218: 111-120
135. 135 Monastirioti M., Linn C. E. Jr and White K. (1996) Characterization of Drosophila tyramine beta-hydroxylase gene and isolation of mutant flies lacking octopamine. J. Neurosci. 16: 3900-3911
136. 136 Prigge S. T., Kolhekar A. S., Eipper B. A., Mains R. E. and Amzel L. M. (1997) Amidation of bioactive peptides: the structure of peptidylglycine alpha-hydroxylating monooxygenase. Science 278: 1300-1305
137. 137 Holm L. and Sander C. (1993) Protein structure comparison by alignment of distance matrices. J. Mol. Biol. 233: 123-138
138. 138 Reedy B. J. and Blackburn N. J. (1994) Preparation and characterization of half-apo dopamine beta-hydroxylase by selective removal of CuA. Identification of a sulfur ligand at the dioxygen binding site by EXAFS and FITR spectroscopy. J. Am. Chem. Soc. 116: 1924-1931
139. 139 Boswell J. S., Reedy B. J., Kulathila R., Merkler D. and Blackburn N. J. (1996) Structural investigations on the coordination environment of the active-site copper centers of recombinant bifunclional peptidylglycine alpha-amidating enzyme. Biochemistry 35: 12241-12250
140. 140 Blackburn N. J., Hasnain S. S., Pettingill T. M. and Strange R. W. (1991) Copper K-extended x-ray absorption fine structure studies of oxidized and reduced dopamine beta-hydroxylase. Confirmation of a sulfur ligand to copper(I) in the reduced enzyme. J. Biol. Chem. 266: 23120-23127
141. 141 Blackburn N. J., Pettingill T. M., Seagraves K. S. and Shigeta R. T. (1990) Characterization of a carbon monoxide complex of reduced dopamine beta-hydroxylase. Evidence for inequivalence of the Cu(I) centers. J. Biol. Chem. 265: 15383-15386
142. 142 Pettingill T. M., Strange R. W. and Blackburn N. J. (1991) Carbonmonoxy dopamine beta-hydroxylase. Structural characterization by Fourier transform infrared, fluorescence and x-ray absorption spectroscopy. J. Biol. Chem. 266: 16996-17003
143. 143 Yonekura H., Anzai T., Kato I., Furuya Y., Shizula S., Takasawa S. et al. (1996) Identification of the five essential histidine residues for peptidylglycine monooxygenase. Biochem. Biophys. Res. Commun. 218: 495-499
144. 144 Ramer S. E., Cheng H., Palcic M. M. and Vederas J. C. (1988) Formation of peptide amides by peptidylglycine alpha-amidating monooxygenase: a new assay and stereochemistry of hydrogen loss. J. Am. Chem. Soc. 110: 8526-8532
145. 145 Francisco W. A., Merkler D. J., Blackburn N. J. and Klinman J. P. (1998) Kinetic mechanism and intrinsic isotope effects for the peptidylglycine alpha-amidating enzyme reaction. Biochemistry 37: 8244-8252
146. 146 Brenner M. C. and Klinman J. P. (1989) Correlation of copper valency with product formation in single turnovers of dopamine beta-monooxygenase. Biochemistry 28: 4664-4670
147. 147 Fitzpatrick P. F. and Villafranca J. J. (1986) The mechanism of inactivation of dopamine beta-hydroxylase by hydrazines. J. Biol. Chem. 261: 4510-4518
148. 148 Battersby A. R., Sheldrake P. W., Staunton J. and Williams D. C. (1976) Studies of enzyme-mediated reactions. Part VII. Stereospecific syntheses of tritium-labelled (2R)-and (2S)-dopamines: stereochemical course of hydroxylation of dopamine by dopamine beta-hydroxylase (E.C. 1.14.17.1). J. Chem. Soc. [Perkin 1]: 1056-1062
149. 149 Bradbury A. F., Mistry J., Roos B. A. and Smyth D. G. (1990) 4-Phenyl-3-butenoic acid, an in vivo inhibitor of peptidylglycine hydroxylase (peptide amidating enzyme). Eur. J. Biochem. 189: 363-368
150. 150 Ping D., Katopodis A. G. and May S. W. (1992) Tandem stereochemistry of peptidylglycine alpha-monooxygenase and petidylamidoglycolate lyase, the two enzymes involved in peptide amidation. J. Am. Chem. Soc, 114: 3998-4000
151. 151 Zabriskie T. M., Cheng H. and Vederas J. C. (1991) Incorporation of oxygen into the hydroxyglycyl intermediate during formation of C-terminal peptide amides by peptidylglycine alpha-amidating monooxygenase (PAM). J. Chem. Soc. [Chem. Commun.] 571-572
152. 13C NMR shift as proof that bifunctional peptidylglycine alpha-amidating enzyme is a monooxygenase. Biochemistry 31: 7282-7288
153. 153 Noguchi M., Seino H., Kochi H., Okamoto M., Tanaka T. and Hirama M. (1992) The source of the oxygen atom in the alpha-hydroxyglycine intermediate of the peptidylglycine alpha-amidating reaction. Biochem. J. 283: 883-888
154. 154 Tian G., Berry J. A. and Klinman J. P. (1994) Oxygen-18 kinetic isotope effects in the dopamine beta-monooxygenase reaction: evidence for a new chemical mechanism in nonheme metallomonooxygenases. Biochemistry 33: 226-234
155. 155 Ahn N. and Klinman J. P. (1983) Mechanism of modulation of dopamine beta-monooxygenase by pH and fumarate as deduced from initial rate and primary deuterium isotope effect studies. Biochemistry 22: 3096-3106
156. 156 Pedersen J. Z. and Finazzi-Agro A. (1991) Protein-radical enzymes. FEBS Lett. 325: 53-58
157. 157 Beratan D. N., Betts J. N. and Onuchic J. N. (1991) Protein electron transfer rates set by the bridging secondary and tertiary structure. Science 252: 1285-1288
158. 158 Beratan D. and Skourtis S. (1998) Electron transfer mechanisms. Curr. Opin. Chem. Biol. 2: 235-243
159. 159 Rhodes C. H. and Honsinger C. (1993) Structure-activity relationships among inhibitors of peptidylglycine amidating monooxygenase. Ann. N.Y. Acad. Sci. 689: 663-666
160. 160 Casara P., Ganzhorn A., Philippo C., Chanal M.-C. and Danzin C. (1996) Unsaturated thioacetic acids as novel mechanism-based inhibitors of peptidylglycine alpha-hydroylating monooxygenase. Bioorg. Med. Chem. Let. 6: 393-396
161. 161 Karlin K. D., Kaderli S. and Zuberbuhler A. D. (1997) Kinetic and thermodynamics of copper(I) dioxygen interaction. Acc. Chem. Res. 30: 139-147
162. 162 Casella L. and Gullotti M. (1993) Dioxygen activation by biomimetic dinuclear complexes. In: Bioinorganic Chemistry of Copper, pp. 292-305, Karlin K. D. and Tyeklar Z. (eds). Chapman and Hall, New York
163. 163 Casella L., Gullotti M., Bartosek M., Pallanza G. and Laurenti E. (1991) Model monooxygenase reactivity by binuclear two-coordinate copper(I) complexes extends to new ligand systems containing nitrogen and sulfur donors. J. Chem. Soc. [Chem. Commun.] 1235-1237
164. 164 Bernhard P. and Anson F.C. (1988) Hydrogen abstraction from amine complexes of Iron(II), Cobalt(II), and Ruthenium(II) by superoxide. Influence of driving force on rate. Inorg. Chem. 27: 4574-4577
165. 165 Hurley T. D., Bosron W. F., Stone C. L. and Amzel L. M. (1994) Structures of three human beta alcohol dehydrogenase variants. Correlations with their functional differences. J. Mol. Biol. 239: 415-429
166. 166 Wimalasena K. and Wimalasena D. S. (1995) The reduction of membrane-bound dopamine beta-monooxygenase in rescaled chromaffin granule ghosts. Is intragranular ascorbic acid a mediator for extragranular reducing equivalents? J. Biol. Chem. 270: 27516-27524
167. 167 Evans S. V. (1993) Hardware-lighted three-dimensional solid model representations of macromolecules. J. Mol. Graph. 11: 134-136
168. 168 Miller S. M. and Klinman J. P. (1985) Secondary isotope effects and structure-reactivity correlations in the dopamine beta-monooxygenase reaction: evidence for a chemical mechanism. Biochemistry 24: 2114-2127
169. 169 Harata M., Jitsukawa K., Masuda H. and Einaga H. (1994) A structurally characterized mononuclear copper(II)-superoxo complex. J. Am. Chem. Soc. 116: 10817-10818